ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 70

$555K Total Retail Price of All Prescriptions

Rank: 19 out of 70

248 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 248 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

25% of this provider’s 248 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,190 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 407 386 S3 1 8
LEVOTHYROXINE SODIUM 332 307 2 2
SIMVASTATIN 318 293 3 1
LISINOPRIL 306 262 4 3
DONEPEZIL HCL 281 281 5 11
FUROSEMIDE 267 248 6 6
AMLODIPINE BESYLATE 248 226 7 5
OMEPRAZOLE 244 238 8 4
METOPROLOL TARTRATE 236 225 9 7
MIRTAZAPINE 222 205 10 20
NAMENDA 218 218 11 13
SERTRALINE HCL 206 174 12 22
WARFARIN SODIUM 197 193 13 10
POTASSIUM CHLORIDE 174 155 14 12
GABAPENTIN 157 129 15 14
CITALOPRAM HBR 147 146 16 16
CARBIDOPA-LEVODOPA 124 124 17 70
LEVEMIR FLEXPEN 124 124 17 136
DIVALPROEX SODIUM 122 91 19 53
RISPERIDONE 119 110 20 32
HYDROCHLOROTHIAZIDE 114 90 21 15
CARVEDILOL 107 106 22 19
NOVOLOG 105 90 23 56
QUETIAPINE FUMARATE 102 96 24 37
ZOLPIDEM TARTRATE 100 94 25 23
LANTUS 96 83 26 38
KLOR-CON M20 86 85 27 79
BACLOFEN 80 24 28 98
FENTANYL 74 63 S2 29 94
ESCITALOPRAM OXALATE 72 72 30 35
TRAMADOL HCL 72 67 30 17
LEVETIRACETAM 68 64 32 59
FLUTICASONE PROPIONATE 68 66 32 47
OXYCODONE HCL-ACETAMINOPHEN 61 61 S2 34 91
CLOPIDOGREL 61 50 34 30
LEVEMIR 60 54 36 126
CYCLOBENZAPRINE HCL 60 58 R 36 103
MELOXICAM 59 50 38 39
OXYBUTYNIN CHLORIDE ER 59 34 38 86
NOVOLOG FLEXPEN 58 53 40 161
RAMIPRIL 57 51 41 125
METFORMIN HCL 56 53 42 9
PLAVIX 55 55 43 43
TAMSULOSIN HCL 55 52 43 29
TRAZODONE HCL 54 53 45 36
HYDRALAZINE HCL 54 45 45 92
BENZTROPINE MESYLATE 54 54 R 45 107
IPRATROPIUM-ALBUTEROL 52 51 48 69
RANITIDINE HCL 51 51 49 26
TERAZOSIN HCL 51 51 49 112
SEROQUEL 50 50 51 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.